News Quantified

ATRA – atara biotherapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Atara Biotherapeutics (NASDAQ:ATRA) was given a new $6.00 price target on by analysts at New Street Research.

Atara Biotherapeutics (NASDAQ:ATRA) had its "hold" rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $6.00 price target on the stock.

Atara Biotherapeutics (NASDAQ:ATRA) was given a new $25.00 price target on by analysts at Canaccord Genuity Group Inc..

Atara Biotherapeutics: An Empty Pipeline With Little Gas [Seeking Alpha]

Atara Biotherapeutics (NASDAQ:ATRA) had its "sell (d+)" rating reaffirmed by analysts at Weiss Ratings.

0.7%

BEAT

5.4%

BEAT

Canaccord Genuity

Canaccord Genuity

Form SCHEDULE 13D/A Atara Biotherapeutics, Filed by: Panacea Innovation Ltd

Form 4 Atara Biotherapeutics, For: Jan 12 Filed by: Huang James

Form 144 Atara Biotherapeutics, Filed by: Panacea Innovation Ltd

Form 8-K Atara Biotherapeutics, For: Jan 12

Form 8-K Atara Biotherapeutics, For: Dec 30

Top News Gainers

3/19 Atara Biotherapeutics Inc (NASDAQ: ATRA) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 25.1%

11/7 Atara Biotherapeutics Announces Third Quarter 2019 Financial Results and Recent Clinical, Operational and Strategic Progress 11.2%

2/5 Atara Biotherapeutics Names Kristin Yarema as Chief Commercial Officer 8.5%

8/9 Atara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] 6.1%

9/10 Atara Biotherapeutics Inc (NASDAQ: ATRA) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 6.0%

2/27 Atara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 5.8%

3/3 Form 4 Atara Biotherapeutics, For: Mar 01 Filed by: Touchon Pascal 5.8%

7/18 Form 424B5 Atara Biotherapeutics, 5.7%

4/22 Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) 5.7%

12/11 Atara Biotherapeutics Inc (NASDAQ: ATRA) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.5%

Top News Decliners

5/9 Q1/2019 3/31/2019 EPS -1.440 ZacksConsensus -1.480 ActVsEst 0.040 - Beat -20.6%

7/16 Atara Biotherapeutics Announces Plan to Initiate Tab-cel® FDA Biologics License Application Submission Next Year -11.9%

2/21 Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) -10.3%

5/12 Atara Biotherapeutics, Inc. 2019 Q1 - Results - Earnings Call Slides [Seeking Alpha] -8.6%

2/19 Atara Biotherapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 27, 2020 -8.4%

10/29 Atara Biotherapeutics Inc (NASDAQ: ATRA) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -7.7%

5/7 Atara Biotherapeutics Inc (NASDAQ: ATRA) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -7.7%

7/16 Atara Biotherapeutics Inc (NASDAQ: ATRA) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -7.3%

6/29 Atara Biotherapeutics Presents Initial ATA188 Phase 1 Safety Results for Patients with Progressive Multiple Sclerosis at the 5th Congress of the European Academy of Neurology (EAN) -7.2%

8/1 Atara Biotherapeutics to Announce Second Quarter 2019 Financial Results and Host Conference Call on Thursday, August 8, 2019 -7.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day